However, whether tolerant p50 dominant NFκB signaling results in impaired IFNβ expression and contributes to worse neonatal and pediatric outcomes in endotoxemia and sepsis is unknown. This evidence concerns the gene IFNB1 and serum lipopolysaccharide activity.